D-dimer testing is primarily indicated to rule out VTE in patients with low or low-to-intermediate clinical pre-test probability, with specific caveats and age-adjusted cut-offs recommended to improve diagnostic accuracy.
Answers are grounded in this paper and cite their sources.
May support D-dimer for VTE rule-out in acute care; leaves open specificity in inflammation.
D-Dimers are formed after degradation of cross-linked fibrin by plasmin.1 Thus, D-dimers indicate the presence of intravascular clot formation and reflect the early process of fibrinolysis. Therefore, D-dimers play an important role for the diagnosis of venous thromboembolism (VTE). Given that D-dimer elevations are not specific to clot formation but may also be encountered after infections or miscellaneous inflammatory processes, the major indication of D-dimers is traditionally to rule out and not to rule in VTE.1,2 D-Dimers should be measured after a thorough clinical evaluation and anamnesis as the decision to measure D-dimer should be restricted to those without potential confounders and a low or low-to-intermediate clinical pre-test probability.2 The latter should be assessed as a gatekeeper before ordering a D-dimer test (Central Illustration) in outpatients using established validated scores such as the Wells or Geneva score, but also using gestalt of an experienced physician.3 Another validated strategy that considers clinical pre-test probability utilizes three items from the Wells score, namely signs of deep venous thrombosis, haemoptysis, and pulmonary embolism (PE) more likely than an alternative diagnosis together with two different D-dimer thresholds.2 Pulmonary embolism is considered to be excluded in patients without clinical items and D-dimer levels < 1000 ng/mL or in patients with one or more clinical items and D-dimer levels < 500 ng/mL. Sequential (stepwise) strategy for selection of eligible candidate for D-dimer testing. ACS, acute coronary syndrome; CT, computed tomography; DD, D-Dimer; DVT, deep venous thrombosis; POC, point-of-care; PPV, positive predictive value; SARS-2, severe acute respiratory syndrome coronavirus type 2; ULN, upper limit of normal; VTE, venous thromboembolism. The measurement of D-dimers in patients with an intermediate pre-test probability requires the availability of a highly sensitive D-dimer test.1 As such, point-of-care assays that have lower sensitivity and negative predictive value (NPV) than laboratory-based assays should only be used in patients with low pre-test probability. D-Dimer concentrations below cut-off can rule out a VTE with a high NPV of >99% (Central Illustration). However, patients with recent trauma, surgery, active cancer, advanced pregnancy beyond the first trimester, infection, or chronic inflammatory disorder should not receive D-dimer testing due to the low diagnostic efficacy and poor specificity. However, as an exception and in order to avoid radiation exposure in pregnant women, current European Society of Cardiology (ESC) guidelines2 promote D-dimer testing beyond the first trimester because—although infrequent—a normal D-dimer still safely rules out VTE in advanced pregnancy. The use of age-adjusted cut-offs may improve the performance of D-dimer testing in the elderly. To improve the low specificity associated with increasing age, an age-specific cut-off has been proposed for patients aged > 50 years. Conversely, patients with a high pre-test probability require a computed tomography (CT) as normal D-dimer cannot reliably rule out a VTE in this situation.1,2 Physicians should be aware of some caveats that might interfere with correct interpretation of D-dimers.1 Besides the presence of positive D-dimers due to confounders that increase D-dimers in the absence of VTE, clinicians should be aware of causes that result in lower D-dimer concentrations including measurement of D-dimer during anticoagulation therapy, particularly if initiated within 24 h before D-dimer testing, in the presence of small or old clots, upper extremity deep venous thrombosis, deficient fibrinolytic system, e.g. tissue plasminogen activator deficiency or high plasminogen activator inhibitor level, measurement of D-dimers in children, and a false-positive CT result from radiology. Infrequently, positive or negative D-dimer concentrations may also be related to pre-analytical or analytical issues. These reasons may include haemolysis, interference, hyperbilirubinaemia, sample clotting, calibration issues, or analyser malfunction. A recent report supports the NPV of normal D-dimers in patients with active cancer patients.4 Not unexpectedly, the prevalence of normal values is low reducing the diagnostic efficacy of D-dimers. On the other hand, it was found that very high D-dimer concentrations in the range of >10-fold upper limit of normal (ULN) were associated with positive predictive values exceeding 80%, irrespective the presence or absence of cancer.4 In agreement, findings on a very high prevalence of VTE and the adverse outcomes associated with increasing values of D-dimers in patients with severe acute respiratory syndrome coronavirus type 2 (SARS-2) infection supported the liberal use of D-dimer testing for detection of VTE and for prognostication of death.5,6 Other members of the Study Group on Biomarkers of the ESC Association for Acute Cardiovascular Care include: Allan Jaffe, MD0; Evangelos Giannitsis, MD1; Lori Daniels, MD2; Kurt Huber, MD3; Johannes Mair, MD;4 Louise Cullen, MD, PhD5; Ola Hammarsten, MD, PhD6; Martin Möckel, MD7; Konstantin Krychtiuk, MD8; Kristian Thygesen, MD9; Matthias Thielmann, MD10 0Departments of Cardiology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA 1Department of Cardiology, University Heidelberg, Germany 2Department of Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, CA, SA 3Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, and Sigmund Freud University, Medical School, Vienna, Austria 4Department of Internal Medicine III—Cardiology and Angiology, Medical University Innsbruck, Austria 5Emergency and Trauma Centre, Royal Brisbane and Women`s Hospital, University of Queensland, Australia 6Department of Clinical Chemistry and Transfusion Medicine, University of Gothenburg, Gothenburg, Sweden 7Division of Emergency Medicine, Charité-Universitätsmedizin Berlin, Germany 8Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria 9Department of Cardiology, Aarhus University Hospital, Denmark 10Klinik für Thorax- und Kardiovaskuläre Chirurgie, Westdeutsches Herz- und Gefäßzentrum Essen, University of Duisburg-Essen, Germany None declared. No new data were generated or analysed in support of this research.
No takes yet. Share an insight, caveat, or question.
Giannitsis et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: